I would ask that you make every effort to attend this important meeting where the updated offer for Adherence Services, received from Mr Joe Brogan in recent days and discussed at CPNI Board meeting, last Thursday 10 March 2022, will be outlined and discussed with contractors.
I would ask you confirm your attendance HERE, if you have not already done so.
Zoom facilities will be available in the event that you cannot attend the meeting in person (Meeting ID: 881 6796 1032 Passcode: 360267). Once you join the meeting via Zoom could I ask you to enter your name and the Pharmacy Contract / Group name in the chatroom box.
Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, Health and Social Care Board.
SUMMARY
Minor Ailments (MA) Service will now become part of the Pharmacy First Service. Pharmacy First for everyday health conditions will launch publicly in March 2022 with associated press releases and social media promotion.
There are no planned changes to the service this year, other than the name change. Patients will be encouraged to see their community pharmacist first for advice and treatment for the 13 conditions currently available under the MA Service.
Service resources including treatment algorithms and formulary are available on the Primary Care Intranet (PCI).
Newly designed promotional materials are available to download from the PCI.
Contracted community pharmacies will continue to offer the Pharmacy First Service for Winter Conditions until 31 March 2022. Please continue to submit activity forms to local offices each month as these will inform funding for future pharmacy services.
The Pharmacy First for Emergency Hormonal Contraception (EHC) ECHO training session which was delivered live on Monday 21 February 2022 was recorded and is now available on the ECHO Moodle site. This recording must be viewed by all pharmacists prior to service delivery.
This pilot service has been available in 62 pilot pharmacies across NI since July 2021. Evaluation of the service is currently underway. Feedback from pharmacists, GP practices and service users has been very positive. It is anticipated that this service will be rolled-out across all community pharmacies later this year following positive evaluation and financial approval.
If you have any queries please contact your local HSCB office.
Please do not hesitate to contact the CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
Please find correspondence HERE from Canice Ward, Head of Medicines Regulatory Group, Department of Health.
SUMMARY
The online questionnaire format proved successful for the 2021 reporting year, the format will remain as an online questionnaire for the 2022 reporting year. There have been some minor changes and the addition of a new question for 2022.
The online questionnaire can be found at HERE and should be completed no later than 31 March 2022. Details relating to completion of the questionnaire are contained in the link.
Further information about the Regulations can be found on the Department’s website.
If you have any queries, regarding the completion of the questionnaire, please contact Aaron McKendry (02890 528628) aaron.mckendry@health-ni.gov.uk or Michelle Keatings (02890 520230) michelle.keatings@health-ni.gov.uk.
Please do not hesitate to contact the CPNI office should you require any further information.
I would ask that you make every effort to attend this important meeting where the updated offer for Adherence Services, received from Mr Joe Brogan in recent days and discussed at CPNI Board meeting, last Thursday 10 March 2022, will be outlined and discussed with contractors.
Zoom facilities will be available in the event that you cannot attend the meeting in person. I would ask you confirm your attendance HERE no later than today, 5pm on Monday 14 March 2022.
A further reminder email will be issued tomorrow, with Zoom joining details being provided to those Contractors wishing to attend remotely. If you have any further queries, please contact CPNI via email ggilvary@communitypharmacyni.co.uk.
I look forward to seeing you on Tuesday evening.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
